Journals / Bezmiâlem Science / 2016 / Cilt: 4 - Sayı: 1

Neuroleptic Malign-like Syndrome Case Management in Intensive Care Unit

Nöroleptik Malign Benzeri Sendrom Nedeniyle Yoğun Bakımda Takip Edilen Olgu

Pages
51–52
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, we present our approach to diagnosis and treatment of a patient with neuroleptic malign-like syndrome in our intensive care unit.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Neuroleptic malign-like syndrome is an emergency condition caused by the withdrawal or dose reduction of anti-Parkinsonian drugs.
📊
Key Findings & Data:Quick treatment and correct diagnosis is important for saving life.
💡
Conclusion & Impact:In this study, we present our approach to diagnosis and treatment of a patient with neuroleptic malign-like syndrome in our intensive care unit.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Neuroleptic malign-like syndrome is an emergency condition caused by the withdrawal or dose reduction of anti-Parkinsonian drugs. Quick treatment and correct diagnosis is important for saving life. Basic clinical findings are rigidity, autonomic dysfunction, fever, elevated serum creatinine kinase levels, and confusion. In this study, we present our approach to diagnosis and treatment of a patient with neuroleptic malign-like syndrome in our intensive care unit.

Özet

Nöroleptik Malign Benzeri Sendrom (NMbS) dopaminerjik ilaçların ani kesilmesi yada doz azaltılması nedeniyle oluşabilen acil bir durumdur. Doğru teşhiş konulması ve tedavinin hızla başlanması hayat kurtarıcıdır. Ateş, rijidite, otonomik disfonksiyon, kreatinin kinaz seviyesinde artış ve bilinç bulanıklığı temel klinik bulgularıdır. Bu sunumuzda, yoğunbakımda takip ettiğimiz NMbS olgusunda teşhiş ve tedavi yaklaşımımızı paylaştık.

🔖

Cite This Article

İDİN, K., ZENGİN, S. Ü., ALVER, S., UYSAL, H., SALİHOĞLU, Z. (2016). Neuroleptic Malign-like Syndrome Case Management in Intensive Care Unit. Bezmiâlem Science, Cilt: 4 - Sayı: 1, 51–52. https://ajindex.com/articles/161496

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Yamawaki Y, Ogawa N. Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) with disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease. Rinshoshinkeigaku 1991; 31: 62-7
  2. Toru M, Matuda O, Makiguchi K, Sugano K. Neuroleptic malignant syndrome-like state following a withdrawal of anti-parkinsonian drugs. J Nerv Ment Dis 1981; 169: 324-6. [CrossRef] 3. Takubo H, Harada T, Hashimoto T, Inaba Y, Kanazawa I, Kuno S, et al. A collaborative study on the malignant syndrome in Parkinson's disease and related disorders. Parkinsonism Relat Disord 2003; 9(Suppl 1): S31-41. [CrossRef] 4. Özkan S, Özbabalık D. Parkinson hastalarında nöroleptik malign-benzeri sendrom. Parkinson Hast Hareket Boz Der 2008; 11: 36-9
  3. Sato Y, Asoh T, Metoki N, Satoh K. Efficacy of methylprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinsons disease. J Neurol Neurosurg Psychiatry 2003; 74: 574-6. [CrossRef] 6. Akyürekli O, Selçuk D. Yoğunbakım olgu sunumu: Nöroleptik malign sendrom benzeri alkol yoksunluk deliryumu. Journal of Neuro Sciences 2009; 26: 251-5
  4. Çe P, Gedizlioğlu M. Herbisid zehirlenmesine bağlı bir malign nöroleptik sendrom benzeri olgu. Journal of Neuro Sciences 2005; 22: 101-3
  5. Meagher LJ, McKay D, Herkes GK, Needham M. Parkinsonism-hyperpyrexia syndrome: the role of electroconvulsive therapy. J Clin Neurosci 2006; 13: 857-9. [CrossRef]